greeksoup/ stock research

Abacus Global Management, Inc.: Q3 FY2026 earnings call

What management said about Q3 FY2026, from the documents filed with the SEC on 5 November 2026: press release. Guidance figures: 2 raised, 2 new. The quarter’s numbers.

Key takeaways

  • Revenue rose 22% to $76.9 million: Total revenue was $76.9 million, up from $63.0 million a year earlier. The company attributed the increase to Life Solutions growth. Source
  • Adjusted EPS rose 20% year over year: Adjusted net income (gross) was $29.4 million, up 24% from $23.6 million. Adjusted EPS (gross) on diluted shares was $0.29, up 20% from $0.24. Source
  • Adjusted EBITDA margin was 55.0%: Adjusted EBITDA was $42.3 million, up 12% from $37.9 million. The margin was 55.0%, against 60.2%, which the company said it maintained while growing the business. Source
  • Third-quarter fund inflows $452.4 million: Longevity fund inflows were $452.4 million in the third quarter, more than six times the prior-year period. Source
  • Nine-month operating cash flow of $167.4 million: Operating cash flow for the nine months was $167.4 million, compared with $(18.2) million a year earlier. The company linked this to cash generation capacity as longevity fund AUM scales. Source
  • Securitization rated investment grade: The $400 million securitization of life insurance policies received an investment-grade rating from a third-party rating agency and was oversubscribed and upsized. Source

“The financial industry has spent decades pricing nearly everything except the one variable that shapes every retirement, which is how long people live.”

Jay Jackson, Chief Executive Officer of Abacus

Guidance

AreaPeriodFigureAgainst last quarter
Adjusted net income (gross) SourceFY 2026$104.5M to $106.5MRaised from $100M to $106M
Adjusted EPS (gross, diluted) SourceFY 2026$1.05 to $1.07Raised from $1.00 to $1.05
Adjusted net income (gross) Source4Q 2026$28M to $30MNew
Adjusted EPS (gross, diluted) Source4Q 2026$0.28 to $0.30New

What changed from last quarter

  • Guidance raised: Full-year 2026 adjusted net income guidance raised from $100M to $106M to $104.5M to $106.5M. Source
  • Guidance raised: Full-year 2026 adjusted EPS guidance raised from $1.00 to $1.05 to $1.05 to $1.07. Source
  • New guidance: Quarterly guidance given for fourth-quarter 2026 adjusted EPS, following third-quarter guidance in the prior release. Source
  • New: Board authorized a $100 million share repurchase program in August. Source
  • New: Company completed a $400 million securitization of life insurance policies in September. Source

Results and growth drivers

  • Revenue rose 22% to $76.9 million: Total revenue was $76.9 million, up from $63.0 million a year earlier. The company attributed the increase to Life Solutions growth. Source
  • Adjusted EPS rose 20% year over year: Adjusted net income (gross) was $29.4 million, up 24% from $23.6 million. Adjusted EPS (gross) on diluted shares was $0.29, up 20% from $0.24. Source
  • Third-quarter EPS above prior range: Third-quarter adjusted EPS of $0.29 was above the $0.26 to $0.28 range given in the August release. The company said results were above the high end of the ranges. Source
  • GAAP net income rose 105%: GAAP net income was $14.5 million, against $7.1 million. The company attributed the increase to revenue growth and lower non-operating expense. Source

Revenue by line

  • Life Solutions revenue fell, related party rose: Life solutions revenue was $37.0 million, against $45.5 million. Life solutions, related party revenue was $34.3 million, against $8.6 million. Source
  • Asset management revenue declined: Asset management, related party revenue was $4.2 million, against $7.6 million. Third-party asset management revenue was $0.8 million, against $1.1 million. Source
  • Technology services revenue more than doubled: Technology services revenue was $0.6 million, against $0.2 million. Nine-month technology services revenue was $1.3 million, against $0.4 million. Source

“We have spent 20 years building the data to price it, and this quarter the business built around that data began working as a single platform.”

Jay Jackson, Chief Executive Officer of Abacus

Margins and costs

  • Adjusted EBITDA margin was 55.0%: Adjusted EBITDA was $42.3 million, up 12% from $37.9 million. The margin was 55.0%, against 60.2%, which the company said it maintained while growing the business. Source
  • General and administrative costs rose: General and administrative expense, including stock-based compensation, was $33.6 million, against $24.7 million. Sales and marketing expense was $5.6 million, against $3.8 million. Source
  • Interest and income tax expense: Interest expense was $10.1 million, against $9.7 million. Income tax expense was $4.2 million, against $4.7 million. Source

Returns and portfolio efficiency

  • Annualized ROE rose to 26%: Annualized ROE was 26%, against 22%. Annualized ROIC was 21%, with the table showing a +40 bps change year over year. Source
  • Turnover ratio above long-term target: Annualized turnover ratio was 3.0x, against 2.0x, which management described as above its 1.5x to 2.0x long-term target. Source
  • Average realized gain fell to 24%: Average realized gain was 24%, against 37%. Management said this exceeds its 20% long-term target and reflects origination discipline. Source

Longevity fund inflows and demand

  • Third-quarter fund inflows $452.4 million: Longevity fund inflows were $452.4 million in the third quarter, more than six times the prior-year period. Source
  • LifeARC inquiries top $500 million: Management said early LifeARC inquiries represent more than $500 million of self-reported investable assets, indicating demand larger than the starting base. Source
  • Interval fund launched in July: The ABX Longevity Growth and Income Fund (ticker ABXGX) launched in July as the company's first registered interval fund for the longevity asset class. Source

Liquidity, debt and cash flow

  • Nine-month operating cash flow of $167.4 million: Operating cash flow for the nine months was $167.4 million, compared with $(18.2) million a year earlier. The company linked this to cash generation capacity as longevity fund AUM scales. Source
  • Cash and debt at quarter end: At September 30, 2026, cash was $104.0 million, balance sheet policy assets at fair value were $370.0 million, and total debt net of issuance costs and discounts was $405.0 million. Source

Capital returns and securitization

  • Buybacks since December 2023 total about $80 million: The company said the new $100 million program builds on about $80 million of common stock repurchased under prior authorized programs since December 2023. Source
  • Securitization rated investment grade: The $400 million securitization of life insurance policies received an investment-grade rating from a third-party rating agency and was oversubscribed and upsized. Source

Figures management reported

FigureReported
Longevity fund inflows, year to date Sourceapproximately $997 million

Earlier plans management reported on

  • Met: Management said revenue growth has been at least 20% in every quarter reported as a public company. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.